Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0440
+0.0020 (4.76%)
Jul 17, 2026, 12:55 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 26.79 million as of July 17, 2026. Its market cap has decreased by -42.83% in one year.
Market Cap
26.79M
Enterprise Value
18.06M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 26.79M, a decrease of -72.10%. That is a compound annual growth rate of -25.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 26.79M | -42.11% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 421.13M |
| Healius | 283.20M |
| Monash IVF Group | 274.69M |
| Cryosite | 63.45M |
| INOVIQ | 31.67M |
| Rhythm Biosciences | 30.08M |
| BCAL Diagnostics | 28.02M |
| ImExHS | 16.76M |